This is an updated set of guidelines for antimicrobial prophylaxis in surgery developed jointly by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Surgical Infection Society, and the Society for Healthcare Epidemiology of America. Key updates include more specific recommendations for optimal timing, dosing, redosing, and duration of antimicrobial therapy.
From the Infectious Disease Division, Summa Health System, Akron, OH and Infectious Disease Section, Northeast Ohio Medical University (NEOMED), Rootstown, OH.
Correspondence to: Thomas M. File, Jr, MD, MSc, MACP, FIDSA, FCCP, Infectious Disease Section, Northeast Ohio Medical University (NEOMED), Rootstown; Ohio Office: 75 Arch St, Suite 506, Akron, OH 44304. E-mail: email@example.com.
The author discloses that he has received recent research funding from Pfizer, Boehringer Ingelheim, Gilead, and Tibotec and has served as a consultant for Bayer, Cerexa/Forest, Durata, GlaxoSmithKline, DaiichiSankyo, Merck, Pfizer, and Tetraphase.